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Cardiac Stem Cell Transplantation Improve Electrophysiological Stability in
Rats with Myocardial Infarction via Inhibition of TGF-b1 Pathway
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Objectives: Whether cardiac stem cells (CSCs) and mesenchymal stem cells (MSCs)
transplantation improved electrophysiological stability in rats with myocardial
infarction (MI) is still unclear. We sought to compare the effects of the CSCs and
MSCs transplantation on the electrophysiological characteristics in rats with MI, and
explore the mechanisms.
Methods: MI was induced in 30 male Sprague-Dawley rats. 2 weeks later, animals
were randomized to receive 5106 CSCs labeled with PKH26 in PBS, 5106 MSCs
labeled with PKH26 in phosphate buffer solution (PBS) or PBS alone injection into
the infarcted anterior ventricular free wall (10 rats for each group). 2 weeks after the
injection, electrophysiological characteristics were measured. Angiotensin II (ANG
II), ANG II type I receptor (AT1), ANG II type II receptor (AT2) and Connexin-43
(Cx43) levels in left ventricular tissues were detected. Finally, we examined Trans-
forming growth factor-b1 (TGF-b1) as well as its downstream signaling molecules in
left ventricular tissues. Labeled CSCs and MSCs were observed in 5 mm cryostat
sections from each heart.
Results: Comparison of MSCs group and PBS group, the electrophysiological sta-
bility was improved in CSCs group (Correct activation recovery time dispersion:
CSCs group vs. MSCs group vs. PBS group: 32.48.8ms vs. 31.731.5ms vs.
63.934.6ms P¼0.0209. ventricular arrhythmias induced rate: CSCs group vs. MSCs
group vs. PBS group: 14/85 vs. 16/41 vs. 22/63 P<0.05. ventricular ﬁbrillation
threshold: CSCs group vs. MSCs group vs. PBS group: 8.91.9mA vs. 3.00.9mA
vs. 3.61.6mA P¼0.0000). CSCs transplantation exhibited reduction of ANG II, and
increase of AT2 and Cx43 in left ventricular tissues. TGF-b1 was decreased in left
ventricular tissues after CSCs transplantation. To the downstream signaling molecules
of TGF-b1, Smad2, Smad3, ERK1/2 and p38 were all decreased, genetically in left
ventricular in CSCs group, while Smad7, in contrary to the above factors, presented a
converse alteration.
Conclusions: CSCs transplantation is superior to MSCs transplantation in modulating
the electrophysiological abnormality in rats with MI. CSCs transplantation provoked
up-regulation of Cx43. However, MSCs rarely provoked Cx43 expression. Inhibition
of TGF-b1 mediated signaling pathway might be involved in the process.
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High density lipoprotein prevents tunicamycin-induced down-regulation of LOX-
1 expression and lipid uptake function in hepatic cells via inhibiting IRE1/XBP-1
pathway
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Objectives: High density lipoprotein (HDL) and endoplasmic reticulum (ER) stress
both regulate lipid metabolism in hepatocytes. Nevertheless, the impact of HDL on ER
stress-mediated alternation of lectin-like oxidized low-density lipoprotein receptor-1
(LOX-1) level remains unclear. Here, we aim to investigate impact on LOX-1
expression by tunicamycin (TM) -induced ER stress and to determine effect of HDL
on TM-affected LOX-1 expression in hepatic L02 cells.
Methods: L02 cells were treated with 0.1-2 mg/ml TM and/or 1-100 mg/ml HDL.
Overexpression or silence of related cellular genes were conducted in TM treated
cells. mRNA expression was evaluated using real time RT-PCR. Protein expression
was analyzed by western blot and immunocytochemistry. Lipid uptake was examined
by oil red O staining and DiI-Ac-LDL labeling followed by ﬂow cytometric analysis.
Results: TM induced upregulation of ER chaperone glucose-regulated protein (GRP)
78, downregulation of LOX-1 expression and lipid uptake. Knocking down of
inositol-requiring kinase/endonuclease-1 (IRE1) or X-box-binding protein-1 (XBP-1)
effectively restored LOX-1 expression and improved lipid uptake in TM treated cells.
HDL treatment blunted the negative impact on LOX-1 expression and lipid uptake
induced by TM. Additionally, HDL at concentration 1-10 mg/ml signiﬁcantly reduced
the GRP78, IRE1 and XBP-1 expressions in TM-treated cells (P<0.01 compared with
TM treatment alone).
Conclusions: Our ﬁndings reveal that HDL could prevent TM-induced reduction of
LOX-1 expression and lipid uptake function via inhibiting IRE1/XBP-1 pathway,
suggesting a new mechanism for beneﬁcial roles of HDL in improving lipid
metabolism.
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Remote limb ischemic postconditioning-induced expression of microRNAs and
its mechanisms in myocardial ischemic/reperfusion injury
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Peking University People’s HospitalC6 JACC Vol 64/16/Suppl C j OctobObjectives: Remote limb ischemic post-conditioning (RIPostC) represents a novel
and potentially promising cardioprotective strategy for preventing from myocardial
ischemia/reperfusion (I/R) injury due to the high feasibility and safety. Previous
research had showed that RIPostC could reduce the myocardial infarction size through
the activation of TRPV1 and its neurotransmitter substance P (SP). Recent studies
showed that microRNA-1 and microRNA-133a play an important role in protecting
heart from I/R injury through their target genes CASP9. Whether microRNA-1 and
microRNA-133 participate in the molecular biological regulation after SP acted on
heart was never been reported. The present study was undertaken to investigate: (1)
RIPostC can regulate the expression of microRNA-1 and microRNA-133a; (2)
TRPV1 receptor and its neurotransmitter SP were responsible for the RIPost-induced
expression of microRNA-1 and microRNA-133a; (3) MicroRNA-1 and microRNA-
133a were involved in myocardial protective effect by regulating apoptosis-related
genes CASP9.
Methods: 1. SD rats were divided into ﬁve groups: Sham-operated group, which the
rats underwent thoracotomy without ligation; I/R group, which the rats were treated
with ischemia for 30 min and reperfusion for 180 min; RIPostC group, which 3 cycles
of transient limb I/R (ischemia 5 min/reperfusion 5 min) were given just after
myocardial reperfusion; RIPostC+ capsazepine (TRPV1 receptor antagonist) group,
which capsazepine (3 mg/kg) was injected into the rats through caudal vein before
myocardial infarction, then 3 cycles of transient limb I/R (ischemia 5 min/reperfusion
5 min) were given just after myocardial reperfusion; RIPostC+ RP67580 (SP receptor
antagonist) group, which RP67580 (5 mg/kg) was injected into the rats through caudal
vein before myocardial infarction, then 3 cycles of transient limb I/R (ischemia 5 min/
reperfusion 5 min) were given just after myocardial reperfusion. 2. The expression of
microRNA-1and microRNA-133a of myocardial tissue in the ﬁve groups was vali-
dated by quantitative real-time RT-PCR. 3. The expression of apoptosis-related genes
CASP9 mRNA of myocardial tissue in the ﬁve groups was validated by quantitative
real-time RT-PCR.
Results: (1) I/R injury could down-regulate the expression of microRNA-1 and
microRNA-133a and up-regulate the expression of CASP9 mRNA; compared with I/
R injury group, RIPostC up-regulated the expression of microRNA-1 and microRNA-
133a and down-regulate the expression of CASP9 mRNA; (2) Compared with
RIPostC only, down-regulated the function of TRPV1 receptor or SP receptor could
down-regulated the expression of microRNA-1 and microRNA-133a and up-regulated
the expression of CASP9 mRNA.
Conclusions: RIPostC could regulate the expression of microRNA-1 and microRNA-
133a by TRPV1 receptor and its neurotransmitter SP. MicroRNA-1 and microRNA-
133a may play an important role in RIPostC protection by regulating apoptosis-related
genes CASP9.
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Objectives: Apelin is a second catalytic substrate for angiotensin-converting enzyme
2 (ACE2). Apelin and its cognate receptor APJ are essential for diverse biological
processes. However, the function of Apelin signaling in the vasculature remains to be
identiﬁed. We evaluated the effectiveness of apelin treatment to inhibit the progression
of angiotensin II (Ang II) -mediated vascular ﬁbrosis in apolipoprotein E-knockout
(KO) mice.
Methods: 3-month wild-type (WT) and ApoEKO mice received with mini-osmotic
pumps with Ang II (1.5 mg/kg/d) or saline for 2 weeks. The Ang II-infused ApoEKO
mice were treated with apelin (200 mg/kg/d) or placebo for 2 weeks. We examined
changes in matrix metalloproteinases (MMP), aortic ultrastructure, and pathological
signaling assessed by real-time PCR, Western blotting, Masson trichrome staining and
transmission electron microscope analysis, respectively.
Results: Chronic Ang II infusion resulted in marked increases in systolic blood
pressure (SBP) levels and aortic expression of TGF-b1, osteopontin (OPN), collagen I,
MMP2 and MMP9 in both WT and ApoE-mutant mice (n¼5-8; P<0.01, respec-
tively). Intriguingly, Ang II treatment led to greater increase in aortic ﬁbrosis in the
ApoEKO mice with exacerbation of aortic ultrastructure injury when compared with
the Ang II-infused WT mice. Downregulation of aortic expression of ACE2 and APJ
receptor was observed in the Ang II-treated ApoEKO mice with activation of phos-
phorylated levels of P-ERK1/2 and P-Smad2 (n¼5-6; P<0.01, respectively). More
importantly, treatment with apelin signiﬁcantly reduced SBP levels and prevented Ang
II-mediated increases in aortic expression of TGF-b1, OPN, collagen I, MMP2,
MMP9, P-ERK1/2 and P-Smad2 in the ApoEKO mice in response to Ang II (n¼4-5;
P<0.05 or P<0.01, respectively). Finally, apelin treatment blunted aortic ﬁbrosis and
enhanced ACE2 level in aortas of the Ang II-infused ApoE-mutant mice (n¼4-5;
P<0.05, respectively), associated with marked attenuation in aortic ultrastructure
injury. However, there were no changes in aortic expression of collagen III and Mas
receptor among groups (n¼4-8; P>0.05; respectively).
Conclusions: Ang II triggers increased aortic ﬁbrosis and severe aortic ultrastructure
injury in the ApoE-deﬁcient mice linked with activation of the TGF-b/Smad/ERK and
MMP signaling. Apelin treatment prevents Ang II-mediated aortic ﬁbrosis ander 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
